Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Michael Egholm

VP and General Manager at Pall Pharmaceuticals


Michael Egholm, Ph.D.

Vice President & General Manager, Biopharmaceuticals

Michael Egholm was appointed vice president and general manager of Biopharmaceuticals at Pall July 2014, after serving as the corporation’s Chief Technology Officer for four years.

Michael Egholm obtained his Ph.D. from University of Copenhagen in 1992 on Peptide Nucleic Acids (PNA) of which he is a co-inventor. Dr. Egholm brings more than two decades of expertise in leading the development and commercialization of innovative technologies. Formerly Chief Technology Officer and vice president of Research & Development at 454 Life Sciences Corp. (a Roche company), he was at the helm of several high-profile programs, including the Neanderthal Sequencing project and the sequencing of the first individual human genome. He has also held senior R&D and market development positions with Molecular Staging and Applied Biosystems. He is a co-author of several highly citied studies (Google Scholar h-index of 76) and elected member of The Royal Danish Academy of Science and Letters in 2018 and The Danish Academy of Technical Sciences in 2015. Furthermore, he is named inventor on over 40 U.S. patents.